# Oncologists’ communication about tobacco and alcohol use during treatment for esophagogastric cancer: a qualitative observational study of simulated consultations

**Authors:** Danique W. Bos-van den Hoek, Loïs F. van de Water, Pieter G. Vos, Meeke Hoedjes, Ruud Roodbeen, Bastiaan R. Klarenbeek, Debby Geijsen, Ellen M. A. Smets, Hanneke W. M. van Laarhoven, Inge Henselmans

PMC · DOI: 10.1007/s00520-024-08847-y · Supportive Care in Cancer · 2024-09-20

## TL;DR

This study examines how oncologists discuss tobacco and alcohol use with simulated patients during consultations for esophagogastric cancer treatment.

## Contribution

The study reveals variation in oncologists' communication about substance use in curative versus palliative settings.

## Key findings

- Oncologists consistently advocated smoking cessation during curative treatment.
- There was more variation in recommendations and arguments regarding alcohol use and in palliative settings.
- Few oncologists actively inquired about the patient's perspective or offered support for behavior change.

## Abstract

Tobacco and alcohol use influence cancer risk as well as treatment outcomes, specifically for esophageal and gastric cancer patients. Therefore, it is an important topic to discuss during consultations. This study aims to uncover medical, radiation, and surgical oncologists’ communication about substance use, i.e., tobacco and alcohol use, in simulated consultations about curative and palliative esophagogastric cancer treatment.

Secondary analyses were performed on n = 40 standardized patient assessments (SPAs) collected in three Dutch clinical studies. Simulated patients with esophagogastric cancer were instructed to ask about smoking or alcohol use during treatment. The responses of the 40 medical, radiation, and surgical oncologists were transcribed verbatim, and thematic analysis was performed in MAXQDA.

Oncologists consistently advocated smoking cessation during curative treatment. There was more variation in their recommendations and arguments in the palliative compared to the curative setting and when addressing alcohol use instead of smoking. Overall, oncologists were less stringent regarding behavior change in the palliative than in the curative setting. Few oncologists actively inquired about the patient’s perspective on the substance use behavior, the recommended substance use change, or the support offered.

Clear guidelines for oncologists on when and how to provide unequivocal recommendations about substance use behavior change and support to patients are needed. Oncologists might benefit from education on how to engage in a conversation about smoking or alcohol.

The online version contains supplementary material available at 10.1007/s00520-024-08847-y.

## Linked entities

- **Diseases:** esophageal cancer (MONDO:0007576), gastric cancer (MONDO:0001056)

## Full-text entities

- **Diseases:** cancer (MESH:D009369), substance use (MESH:D019966), smoking (MESH:D015208), esophageal and gastric cancer (MESH:D013274)
- **Chemicals:** alcohol (MESH:D000438)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11415438/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11415438/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC11415438/full.md

---
Source: https://tomesphere.com/paper/PMC11415438